Please login to the form below

Not currently logged in
Email:
Password:

Portfolio Analysis

This page shows the latest Portfolio Analysis news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Finance and investment

  • Deal Watch March 2017 Deal Watch March 2017

    Sartorius. Acquisition. Platform, instrumentation, software and reagents for real-time live cell analysis. ... 320. Neurovance. Otsuka. Acquisition. Portfolio, including centanafadine in ADHD, with phase II complete.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....